Orion OYJ (OTCMKTS:ORINY) Shares Gap Up – Here’s Why

Orion OYJ Unsponsored ADR (OTCMKTS:ORINY)’s stock price gapped up prior to trading on Friday . The stock had previously closed at $35.28, but opened at $39.13. Orion OYJ shares last traded at $39.13, with a volume of 129 shares trading hands.

Wall Street Analysts Forecast Growth

Separately, Nordea Equity Research raised shares of Orion OYJ from a “hold” rating to a “buy” rating in a report on Monday, October 6th. One investment analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy”.

Orion OYJ Stock Up 6.2%

The stock has a market capitalization of $11.05 billion, a price-to-earnings ratio of 31.56 and a beta of 0.05. The company has a quick ratio of 1.19, a current ratio of 1.99 and a debt-to-equity ratio of 0.13. The stock has a 50 day moving average price of $34.70 and a 200 day moving average price of $37.49.

Orion OYJ (OTCMKTS:ORINY) last posted its earnings results on Tuesday, October 28th. The company reported $0.40 EPS for the quarter. Orion OYJ had a net margin of 19.33% and a return on equity of 31.36%. The business had revenue of $494.69 million for the quarter. As a group, analysts forecast that Orion OYJ Unsponsored ADR will post 1.18 EPS for the current year.

About Orion OYJ

Orion Corporation (Orion Oyj) is a Finland-based pharmaceutical company engaged in the research, development, manufacture and marketing of human and veterinary medicines as well as diagnostic tests. The company’s core therapeutic areas include central nervous system disorders, oncology and respiratory diseases, and it offers both proprietary and generic products. Orion’s product range spans from small-molecule drugs and active pharmaceutical ingredients to radiodiagnostic imaging agents and line extensions developed through in-house research.

Since its founding in 1917 in Helsinki, Orion has grown into an integrated pharmaceuticals business with state-of-the-art manufacturing facilities in Finland and France.